Targeted Combo Topples Chemo in Pediatric Glioma With BRAF Mutations

(MedPage Today) -- CHICAGO -- Dual targeted therapy with a BRAF and MEK inhibitor quadrupled responses in pediatric BRAF-mutant low-grade glioma and reduced risk of disease progression or death compared with standard chemotherapy, a phase II...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news